4
Changes in Ownership
Protalix BioTherapeutics, Inc. Filed Acc 0001144204-13-014648
Director sold 35,198 shares at an average $5.79 ($203,805)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Akirov Alfred Director | 2013-03-08 | Sale | −10,000 | $5.82 | $58,200 | 5,062,911 | I |
| Akirov Alfred Director | 2013-03-08 | Sale | −2,500 | $5.91 | $14,775 | 5,060,411 | I |
| Akirov Alfred Director | 2013-03-08 | Sale | −2,500 | $5.92 | $14,800 | 5,057,911 | I |
| Akirov Alfred Director | 2013-03-08 | Sale | −1,898 | $5.95 | $11,293 | 5,056,013 | I |
| Akirov Alfred Director | 2013-03-11 | Sale | −300 | $5.79 | $1,737 | 5,055,713 | I |
| Akirov Alfred Director | 2013-03-11 | Sale | −3,000 | $5.75 | $17,250 | 5,052,713 | I |
| Akirov Alfred Director | 2013-03-11 | Sale | −10,000 | $5.72 | $57,200 | 5,042,713 | I |
| Akirov Alfred Director | 2013-03-11 | Sale | −5,000 | $5.71 | $28,550 | 5,037,711 | I |
| Open-market sales · 35,198 sh · avg $5.79 · $203,805 | |||||||
Loading xslF345X03/v337975_4.xml…